Anti-CD33 Monoclonal Antibody BI 836858
Semantic Scholar uses AI to extract papers important to this topic.
Acute myeloid leukemia (AML) is the second most common type of leukemia in adults. Incidence of AML increases with age with a… (More)
- Expert opinion on investigational drugs
There is long-standing interest in drugs targeting the myeloid differentiation antigen CD33 in acute myeloid… (More)
We recently reported that the accumulation of myeloid-derived suppressor cells (MDSC), defined as CD33+HLA-DR−Lin−, has a direct… (More)
Acute myeloid leukemia (AML) is the most common type of acute leukemia, affecting older individuals at a median age of 67 years… (More)
Serial evaluation in patients treated with a 10-day course of decitabine demonstrated higher BI 836858–mediated ADCC at day 28… (More)